loading
Schlusskurs vom Vortag:
$3.91
Offen:
$3.94
24-Stunden-Volumen:
12,265
Relative Volume:
0.01
Marktkapitalisierung:
$291.66M
Einnahmen:
$405.47M
Nettoeinkommen (Verlust:
$53.66M
KGV:
5.4236
EPS:
0.72
Netto-Cashflow:
$131.28M
1W Leistung:
-2.99%
1M Leistung:
+3.17%
6M Leistung:
-10.14%
1J Leistung:
-44.84%
1-Tages-Spanne:
Value
$3.89
$3.94
1-Wochen-Bereich:
Value
$3.865
$4.06
52-Wochen-Spanne:
Value
$3.52
$8.04

Orasure Technologies Inc Stock (OSUR) Company Profile

Name
Firmenname
Orasure Technologies Inc
Name
Telefon
(503) 641-6115
Name
Adresse
220 E FIRST ST, BETHLEHEM, PA
Name
Mitarbeiter
638
Name
Twitter
@orasure
Name
Nächster Verdiensttermin
2024-11-06
Name
Neueste SEC-Einreichungen
Name
OSUR's Discussions on Twitter

Vergleichen Sie OSUR mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Medical Instruments & Supplies icon
OSUR
Orasure Technologies Inc
3.90 291.66M 405.47M 53.66M 131.28M 0.72
Medical Instruments & Supplies icon
ISRG
Intuitive Surgical Inc
587.77 209.89B 8.35B 2.32B 1.30B 6.41
Medical Instruments & Supplies icon
BDX
Becton Dickinson Co
227.26 68.23B 20.18B 1.71B 3.07B 5.94
Medical Instruments & Supplies icon
ALC
Alcon Inc
91.10 45.33B 9.76B 1.16B 665.00M 2.34
Medical Instruments & Supplies icon
RMD
Resmed Inc
237.78 34.84B 4.93B 1.25B 1.38B 8.47
Medical Instruments & Supplies icon
WST
West Pharmaceutical Services Inc
331.46 23.97B 2.88B 499.60M 321.60M 6.74

Orasure Technologies Inc Stock (OSUR) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2023-01-03 Fortgesetzt Evercore ISI In-line
2021-09-22 Herabstufung Raymond James Outperform → Mkt Perform
2020-08-21 Eingeleitet Evercore ISI Outperform
2020-08-10 Eingeleitet Citigroup Buy
2020-08-10 Eingeleitet JP Morgan Neutral
2020-08-07 Hochstufung Raymond James Mkt Perform → Outperform
2020-06-25 Eingeleitet Lake Street Buy
2020-04-21 Fortgesetzt Stephens Equal-Weight
2018-10-23 Fortgesetzt Raymond James Mkt Perform
2018-07-16 Herabstufung Stephens Overweight → Equal-Weight
2017-11-02 Herabstufung Jefferies Buy → Hold
2017-02-09 Hochstufung Raymond James Mkt Perform → Outperform
2016-06-13 Herabstufung Raymond James Outperform → Mkt Perform
2015-11-05 Bestätigt Mizuho Buy
2015-05-07 Herabstufung JMP Securities Mkt Outperform → Mkt Perform
2015-01-23 Bestätigt Mizuho Buy
2014-06-12 Bestätigt Canaccord Genuity Buy
2014-06-11 Bestätigt Mizuho Buy
2012-12-21 Eingeleitet Mizuho Buy
2012-08-08 Hochstufung Barrington Research Mkt Perform → Outperform
2012-07-05 Herabstufung Barrington Research Outperform → Mkt Perform
2012-03-27 Eingeleitet JMP Securities Mkt Outperform
Alle ansehen

Orasure Technologies Inc Aktie (OSUR) Neueste Nachrichten

pulisher
Feb 06, 2025

OraSure Technologies (NASDAQ:OSUR) Stock Rating Upgraded by StockNews.com - MarketBeat

Feb 06, 2025
pulisher
Feb 06, 2025

Microbiomes Market to Grow by USD 824.3 Million (2025-2029) with Rising Disease Prevalence Boosting the Market, Report on How AI is Redefining Market LandscapeTechnavio - Yahoo Finance

Feb 06, 2025
pulisher
Feb 06, 2025

OraSure Technologies, Inc. to Host Earnings Call - ACCESS Newswire

Feb 06, 2025
pulisher
Feb 04, 2025

Exchange Traded Concepts LLC Invests $287,000 in OraSure Technologies, Inc. (NASDAQ:OSUR) - MarketBeat

Feb 04, 2025
pulisher
Feb 04, 2025

Does Orasure Technologies Inc (OSUR) offer a good opportunity for investors? - SETE News

Feb 04, 2025
pulisher
Feb 01, 2025

OraSure Technologies (NASDAQ:OSUR) Rating Lowered to "Hold" at StockNews.com - MarketBeat

Feb 01, 2025
pulisher
Jan 31, 2025

Head-To-Head Contrast: PolyPid (NASDAQ:PYPD) versus OraSure Technologies (NASDAQ:OSUR) - Defense World

Jan 31, 2025
pulisher
Jan 27, 2025

OraSure (OSUR) Upgraded to Strong Buy: What Does It Mean for the Stock? - MSN

Jan 27, 2025
pulisher
Jan 27, 2025

New Strong Buy Stocks for January 27th - Yahoo Finance

Jan 27, 2025
pulisher
Jan 23, 2025

Should Value Investors Buy OraSure Technologies (OSUR) Stock? - Yahoo Finance

Jan 23, 2025
pulisher
Jan 19, 2025

JPMorgan Chase & Co. Grows Position in OraSure Technologies, Inc. (NASDAQ:OSUR) - Defense World

Jan 19, 2025
pulisher
Jan 18, 2025

Point of Care Weekly Newsletter - substack.com

Jan 18, 2025
pulisher
Jan 17, 2025

OraSure Technologies (NASDAQ:OSUR) Upgraded at StockNews.com - MarketBeat

Jan 17, 2025
pulisher
Jan 17, 2025

OraSure Technologies (NASDAQ:OSUR) Upgraded to “Buy” at StockNews.com - Defense World

Jan 17, 2025
pulisher
Jan 16, 2025

Global At-Home Testing Market to Reach USD 11,877.8 Million by 2035 with a CAGR of 4.8%, Driven by Rising Consumer Demand for Self-Diagnostic Tools | Future Market Insights, Inc. - GlobeNewswire Inc.

Jan 16, 2025
pulisher
Jan 16, 2025

New Strong Buy Stocks for January 16th - Yahoo Finance

Jan 16, 2025
pulisher
Jan 16, 2025

Barclays PLC Buys 126,503 Shares of OraSure Technologies, Inc. (NASDAQ:OSUR) - Defense World

Jan 16, 2025
pulisher
Jan 16, 2025

OraSure Technologies, Inc. (NASDAQ:OSUR) Shares Bought by Barclays PLC - MarketBeat

Jan 16, 2025
pulisher
Jan 15, 2025

Bethlehem manufacturer puts original headquarters up for sale - MSN

Jan 15, 2025
pulisher
Jan 15, 2025

Over-the-Counter HIV Test Approved for Adolescents - Pulmonology Advisor

Jan 15, 2025
pulisher
Jan 15, 2025

Retractable Technologies (NYSE:RVP) and OraSure Technologies (NASDAQ:OSUR) Critical Contrast - Defense World

Jan 15, 2025
pulisher
Jan 14, 2025

NOWDiagnostics Faces Off With Biotech Rival In Trade Secrets Lawsuit - Arkansas Business

Jan 14, 2025
pulisher
Jan 13, 2025

NOWDiagnostics Responds with Countersuit Against Frivolous OraSure Claims - BioSpace

Jan 13, 2025
pulisher
Jan 09, 2025

OraSure leaving original manufacturing site in Bethlehem - 69News WFMZ-TV

Jan 09, 2025
pulisher
Jan 09, 2025

OraSure Technologies (NASDAQ:OSUR) Downgraded by StockNews.com to "Hold" - MarketBeat

Jan 09, 2025
pulisher
Jan 08, 2025

OraSure Technologies’ Acquisition of Sherlock Biosciences - Global Legal Chronicle

Jan 08, 2025
pulisher
Jan 08, 2025

OraSure to Present at the J.P Morgan Healthcare Conference - The Manila Times

Jan 08, 2025
pulisher
Jan 07, 2025

OraSure Technologies, Inc.'s OraQuick HIV Self-Test Receives Approval for Use in Adolescents - Marketscreener.com

Jan 07, 2025
pulisher
Jan 07, 2025

NEUBERGER BERMAN GROUP LLC Adjusts Holdings in OraSure Technologies Inc - GuruFocus.com

Jan 07, 2025
pulisher
Jan 07, 2025

OraSure Technologies to Present at J.P. Morgan Healthcare Conference 2025 - StockTitan

Jan 07, 2025
pulisher
Jan 07, 2025

Are Investors Undervaluing OraSure Technologies (OSUR) Right Now? - Yahoo Finance

Jan 07, 2025
pulisher
Jan 07, 2025

FDA Expands OraSure's HIV Self-Test Access to Teens Amid Rising Youth Diagnoses - StockTitan

Jan 07, 2025
pulisher
Jan 07, 2025

CORRECTIONOraQuick® HIV Self-Test Now Approved for Use in Adolescents - GlobeNewswire

Jan 07, 2025
pulisher
Jan 07, 2025

OraQuick® HIV Self-Test Now Approved for Use in Adolescents - The Manila Times

Jan 07, 2025
pulisher
Jan 07, 2025

OraSure Expands OraQuick HIV Self-Test Access to Teens 14+ Amid Rising Youth Cases - StockTitan

Jan 07, 2025
pulisher
Jan 03, 2025

OSUR Stock Surges Over 5% Amid Market Activity - GuruFocus.com

Jan 03, 2025
pulisher
Jan 03, 2025

Geode Capital Management LLC Purchases 32,929 Shares of OraSure Technologies, Inc. (NASDAQ:OSUR) - Defense World

Jan 03, 2025
pulisher
Jan 02, 2025

OraSure in 2025: Changes, challenges and silver linings - 69News WFMZ-TV

Jan 02, 2025
pulisher
Jan 02, 2025

OraSure Technologies (NASDAQ:OSUR) Upgraded by StockNews.com to Buy Rating - Defense World

Jan 02, 2025
pulisher
Jan 01, 2025

Barclays PLC Raises Holdings in OraSure Technologies, Inc. (NASDAQ:OSUR) - Defense World

Jan 01, 2025
pulisher
Dec 29, 2024

OraSure Technologies, Inc. (NASDAQ:OSUR) Shares Bought by Jane Street Group LLC - Defense World

Dec 29, 2024
pulisher
Dec 29, 2024

OraSure Technologies, Inc. (NASDAQ:OSUR) Shares Bought by Franklin Resources Inc. - Defense World

Dec 29, 2024
pulisher
Dec 29, 2024

OraSure Technologies Completes Acquisition of Sherlock Biosciences, Inc. - Defense World

Dec 29, 2024

Finanzdaten der Orasure Technologies Inc-Aktie (OSUR)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$64.83
price down icon 0.73%
$22.18
price up icon 1.50%
medical_instruments_supplies BAX
$30.88
price down icon 1.89%
$221.00
price up icon 1.82%
medical_instruments_supplies COO
$95.34
price up icon 0.09%
medical_instruments_supplies WST
$331.46
price down icon 1.10%
Kapitalisierung:     |  Volumen (24h):